Navigation Links
Ingram Micro to Distribute New Fujitsu Biometric Login Products for Novell eDirectory in United States
Date:1/9/2008

Fingerprint Sensor Solutions are Expanding eDirectory Applications and Technology in Financial, Educational, Health Care and Government Sectors

SUNNYVALE, Calif., Jan. 9 /PRNewswire-FirstCall/ -- Ingram Micro Inc. (NYSE: IM), the world's largest technology distributor, has signed an agreement with Fujitsu Microelectronics America, Inc. (FMA) to distribute the Fujitsu biometric login interface products for Novell(R) eDirectory(TM) and Novell Access Manager. The contract covers distribution in the United States and its territories. A similar contract initiating Canadian distribution was signed in August. (See a related press release dated August 7, 2007, http://www.fujitsu.com/us/news/pr/fma_20070807-2.html.)

Fujitsu Microelectronics and 123ID, Inc. have developed biometric login solutions to allow database users access to Novell eDirectory applications running on Linux, NetWare and Windows. This biometric solution replaces password authentication with eDirectory logon, which provides uncompromised security, capability and pricing. The authentication technology is designed for use in the wide range of financial, educational, medical, and government applications that are served by Novell eDirectory. (See a related press release dated August 7, 2007, http://www.fujitsu.com/us/news/pr/fma_20070807-1.html.)

"We are pleased to extend this distribution agreement between Fujitsu Microelectronics America and Ingram Micro to the U.S.," said Keith Horn, chief operating officer, Fujitsu Microelectronics America. "The company's global leadership in distribution, sales, an
'/>"/>

SOURCE Ingram Micro Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology news :

1. Making sense of antisense microRNAs
2. Tips from the Journals of the American Society for Microbiology
3. UAB microbiologist wins top Czech science honor
4. It is important to demonstrate the influence of the microenvironment in the process of metastasis
5. Elevated carbon dioxide changes soil microbe mix below plants
6. NIH launches Human Microbiome Project
7. Unique porous copper structure enables new generation of military micro-detonators
8. Nitrous oxide from ocean microbes
9. Methane from microbes: a fuel for the future
10. Scientists melt million-year-old ice in search of ancient microbes
11. Fidelica Microsystems Announces Biometrically-Authenticated Smart Card
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/27/2015)... , April 27, 2015  For more than four ... show has been the premier worldwide event for the ... is a must-attend event for any local, national, or ... the emerging commercial markets and current applications of unmanned ... of this projected $48 billion industry, and how it ...
(Date:4/20/2015)... Huntington Memorial Hospital is the first facility ... miniaturized, wireless monitoring sensor to manage heart failure (HF). ... FDA-approved heart failure monitoring device that has been proven ... to manage heart failure. The CardioMEMS HF ... pulmonary artery (PA) during a non-surgical procedure to directly ...
(Date:4/14/2015)... 14, 2015 NXT-ID, Inc. (NASDAQ: NXTD ... focused on the growing mobile commerce market, announces that ... 2015 New York Design Awards under the category  ,Product ... City Design Awards are part of a global multi-disciplinary ... ratings from the marketplace, industry and judging panel. Winners ...
Breaking Biology News(10 mins):UNMANNED SYSTEMS 2015: Largest International Conference and Trade Show for the Drone and Unmanned Technology Industry 2UNMANNED SYSTEMS 2015: Largest International Conference and Trade Show for the Drone and Unmanned Technology Industry 3UNMANNED SYSTEMS 2015: Largest International Conference and Trade Show for the Drone and Unmanned Technology Industry 4UNMANNED SYSTEMS 2015: Largest International Conference and Trade Show for the Drone and Unmanned Technology Industry 5Huntington Memorial Hospital Becomes First in the San Gabriel Valley to Offer Patients a New Heart Failure Monitoring Solution 2Huntington Memorial Hospital Becomes First in the San Gabriel Valley to Offer Patients a New Heart Failure Monitoring Solution 3NXT-ID's Wocket Smart Wallet Nominated for 2015 New York Design Awards in 'Product Design- Technology' 2NXT-ID's Wocket Smart Wallet Nominated for 2015 New York Design Awards in 'Product Design- Technology' 3
... neuroscientists at Georgetown University Medical Center found significant differences ... dyslexia to their non-dyslexic control groups, suggesting that the ... sex., Their study, investigating dyslexia in both males and ... of females with and without dyslexia (in children and ...
... of tissue during surgical operations has the potential to ... to conventional sutures and stapling in intestinal surgery, scientists ... gold-based solder, or sealing material, appears in the journal ... colleagues explain that laser tissue welding (LTW) is a ...
... Sydney, Australia -- Researchers from the University of ... is needed to understand how micro-organisms respond to ... in medical and environmental applications. Although nanosilver ... to silver nano-particles can cause other potentially harmful ...
Cached Biology News:Brain anatomy of dyslexia is not the same in men and women, boys and girls 2Bacteria adapt and evade nanosilver's sting -- new study 2
(Date:5/22/2015)... 2015  Actavis plc (NYSE: ACT ) today ... Appeals for the Second Circuit has issued a ruling ... Company to continue distribution of NAMENDA ® (memantine ...   "While we are disappointed by ... to continue our strong efforts to convey the significant ...
(Date:5/22/2015)... NJ (PRWEB) May 22, 2015 ... new white paper that explores the potential of big ... The white paper was developed to help life sciences ... can leverage data to gain critical business insights. , ... large amounts of data driven by patient profiling, compliance ...
(Date:5/21/2015)... (PRWEB) May 21, 2015 Seventh Wave ... safety and efficacy of pharmaceutical products and medical devices, ... Heights, MO 63043, a 50,000 sq. ft. building more ... to enable strategic growth. Facility renovations will begin immediately ... new space will occur in September. , “We ...
(Date:5/21/2015)... YORK , May 21, 2015  Prima Biomed ... company that is striving to become a leader in ... cancer, recently announced that the final CVac data from ... shown a clear trend for a clinically meaningful improvement ... in second remission patients. In the group ...
Breaking Biology Technology:Actavis Confirms Appeals Court Ruling Requiring Continued Distribution of NAMENDA IR 2Actavis Confirms Appeals Court Ruling Requiring Continued Distribution of NAMENDA IR 3Actavis Confirms Appeals Court Ruling Requiring Continued Distribution of NAMENDA IR 4Actavis Confirms Appeals Court Ruling Requiring Continued Distribution of NAMENDA IR 5Actavis Confirms Appeals Court Ruling Requiring Continued Distribution of NAMENDA IR 6Actavis Confirms Appeals Court Ruling Requiring Continued Distribution of NAMENDA IR 7Actavis Confirms Appeals Court Ruling Requiring Continued Distribution of NAMENDA IR 8New White Paper Explores the Potential of Big Data Analytics in Life Sciences and Healthcare 2Seventh Wave Laboratories Purchases Building for Expansion, Upcoming Move 2Seventh Wave Laboratories Purchases Building for Expansion, Upcoming Move 3Correction Continues after Big Move - BrokerBank Securities, Inc. 2
... Cardium Therapeutics,(NYSE: CXM ) today reported ... of Medicine showing the long-term outcome of a method ... disorder of the immune system.,The infant children studied had ... arises in infants with a genetic defect that,leaves them ...
... Shares of Common StockAt a Price of $5.00 per ... Group, Inc. (the "Company" or "PharmaNet") (Nasdaq: ... today announced that it has signed a definitive merger ... ("JLL"). Under the terms of the Merger Agreement, JLL ...
... Secondary Endpoints -- CAPACITY 1 Misses Primary Endpoint, Provides ... MAA -BRISBANE, Calif., Feb. 3 InterMune, Inc. (Nasdaq: ... two Phase 3 CAPACITY studies evaluating pirfenidone in patients ... of change in percent predicted Forced Vital Capacity (FVC) ...
Cached Biology Technology:Gene Therapy Field Advances With Important Clinical Findings Reported in the New England Journal of Medicine 2Gene Therapy Field Advances With Important Clinical Findings Reported in the New England Journal of Medicine 3Gene Therapy Field Advances With Important Clinical Findings Reported in the New England Journal of Medicine 4Gene Therapy Field Advances With Important Clinical Findings Reported in the New England Journal of Medicine 5PharmaNet Development Group Agrees to be Acquired by JLL Partners 2PharmaNet Development Group Agrees to be Acquired by JLL Partners 3PharmaNet Development Group Agrees to be Acquired by JLL Partners 4PharmaNet Development Group Agrees to be Acquired by JLL Partners 5PharmaNet Development Group Agrees to be Acquired by JLL Partners 6PharmaNet Development Group Agrees to be Acquired by JLL Partners 7InterMune Reports Results of Two Phase 3 CAPACITY Studies of Pirfenidone in IPF 2InterMune Reports Results of Two Phase 3 CAPACITY Studies of Pirfenidone in IPF 3InterMune Reports Results of Two Phase 3 CAPACITY Studies of Pirfenidone in IPF 4InterMune Reports Results of Two Phase 3 CAPACITY Studies of Pirfenidone in IPF 5InterMune Reports Results of Two Phase 3 CAPACITY Studies of Pirfenidone in IPF 6InterMune Reports Results of Two Phase 3 CAPACITY Studies of Pirfenidone in IPF 7InterMune Reports Results of Two Phase 3 CAPACITY Studies of Pirfenidone in IPF 8InterMune Reports Results of Two Phase 3 CAPACITY Studies of Pirfenidone in IPF 9InterMune Reports Results of Two Phase 3 CAPACITY Studies of Pirfenidone in IPF 10InterMune Reports Results of Two Phase 3 CAPACITY Studies of Pirfenidone in IPF 11
The Protein Kinase Factsbooks (2 Volume Set)...
... PhastGel DNA Silver Staining Kit, 1. ... gels.Separate proteins and peptides on denaturing, ... and improve reproducibility with precast gels, ... sensitivity comparable to that of radioisotopes ...
ANTI S. ENT TOX BC2D...
Porcine Serum US Origin 6 Months or Older...
Biology Products: